The current authors conducted an open up-label pilot research that administered psilocybin to 15 cure-resistant tobacco/nicotine-dependent people who smoke, during the context of cognitive behavioral therapy for cigarette smoking cessation [58]. Participants had been administered ~0.29 mg/kg oral psilocybin to the participant’s target date to Sto